Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer’s disease

[1]  N. Ranson,et al.  The in-tissue molecular architecture of β-amyloid pathology in the mammalian brain , 2023, Nature communications.

[2]  D. Sehlin,et al.  Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer’s disease , 2023, Alzheimer's Research & Therapy.

[3]  D. Selkoe,et al.  Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer’s disease brains , 2023, Neuron.

[4]  J. Louis,et al.  Structures of brain-derived 42-residue amyloid-β fibril polymorphs with unusual molecular conformations and intermolecular interactions , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Murzin,et al.  Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains , 2022, bioRxiv.

[6]  L. Lannfelt,et al.  Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer’s Disease , 2022, Neurotherapeutics.

[7]  Silvio R. Meier,et al.  A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice , 2022, Neurotherapeutics.

[8]  James A. Geraets,et al.  The 3D structure of lipidic fibrils of α-synuclein , 2022, bioRxiv.

[9]  A. Murzin,et al.  Cryo-EM structures of amyloid-β 42 filaments from human brains , 2022, Science.

[10]  Mina Esmail Zadeh Nojoo Kambar,et al.  Alzheimer's disease drug development pipeline: 2022 , 2022, Alzheimer's & dementia.

[11]  L. Petrucelli,et al.  Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains , 2021, Cell.

[12]  N. Shah,et al.  Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography , 2021, Frontiers in Neuroscience.

[13]  G. Schröder,et al.  Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids. , 2021, Chemical reviews.

[14]  Silvio R. Meier,et al.  11C-PiB and 124I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention , 2021, The Journal of Nuclear Medicine.

[15]  J. Götz,et al.  A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease , 2021, Alzheimer's Research & Therapy.

[16]  D. Berry,et al.  A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody , 2020, Alzheimer's Research & Therapy.

[17]  Conrad C. Huang,et al.  UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.

[18]  Luisa U. Schäfer,et al.  Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-β fibrils , 2020, Nature Structural & Molecular Biology.

[19]  R. Tycko,et al.  Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue , 2020, Proceedings of the National Academy of Sciences.

[20]  Paul Emsley,et al.  Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data , 2019, Protein science : a publication of the Protein Society.

[21]  C. Sigurdson,et al.  Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue , 2019, Nature Communications.

[22]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[23]  Thorsten Wagner,et al.  SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM , 2019, Communications Biology.

[24]  A. Harris,et al.  Immunoelectron Microscopy of Viral Antigens , 2019, Current protocols in microbiology.

[25]  A. King.  The search for better animal models of Alzheimer’s disease , 2018, Nature.

[26]  D. Tegunov,et al.  Real-time cryo–EM data pre-processing with Warp , 2018, Nature Methods.

[27]  L. Lannfelt,et al.  Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody , 2018, Alzheimer's Research & Therapy.

[28]  Christopher J. Williams,et al.  MolProbity: More and better reference data for improved all‐atom structure validation , 2018, Protein science : a publication of the Protein Society.

[29]  G. Schröder,et al.  Fibril structure of amyloid-β(1–42) by cryo–electron microscopy , 2017, Science.

[30]  Karsten Melcher,et al.  Amyloid beta: structure, biology and structure-based therapeutic development , 2017, Acta Pharmacologica Sinica.

[31]  C. Dobson,et al.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.

[32]  T. Wisniewski,et al.  Alzheimer’s disease: experimental models and reality , 2017, Acta Neuropathologica.

[33]  Sjors H.W. Scheres,et al.  Helical reconstruction in RELION , 2016, bioRxiv.

[34]  P. Sjövall,et al.  Probing amyloid‐β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry , 2016, Journal of neurochemistry.

[35]  Peter Güntert,et al.  Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril , 2016, Proceedings of the National Academy of Sciences.

[36]  Sara Linse,et al.  Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils. , 2016, Journal of the American Chemical Society.

[37]  L. Lannfelt,et al.  Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody , 2016, Alzheimer's Research & Therapy.

[38]  G. Antoni,et al.  Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease , 2016, Nature Communications.

[39]  N. Grigorieff,et al.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.

[40]  D. Borchelt,et al.  Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains , 2015, Neurobiology of Aging.

[41]  G. Schröder,et al.  Improving the visualization of cryo-EM density reconstructions. , 2015, Journal of structural biology.

[42]  Timo Grimmer,et al.  FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice , 2015, EJNMMI Research.

[43]  Ruth Nussinov,et al.  Aβ(1–42) Fibril Structure Illuminates Self-recognition and Replication of Amyloid in Alzheimer’s , 2015, Nature Structural &Molecular Biology.

[44]  R. Glockshuber,et al.  Atomic-Resolution Three-Dimensional Structure of Amyloid β Fibrils Bearing the Osaka Mutation , 2014, Angewandte Chemie.

[45]  M. Scheinin,et al.  In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol , 2014, EJNMMI Research.

[46]  J. Cummings,et al.  Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.

[47]  R. Franco,et al.  Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans? , 2014, Front. Pharmacol..

[48]  T. Leergaard,et al.  Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice , 2014, Neurobiology of Aging.

[49]  G. Schellenberg,et al.  The Arctic AβPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Aβ , 2013, Acta neuropathologica communications.

[50]  M. Scheinin,et al.  Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease , 2013, The Journal of Nuclear Medicine.

[51]  Gunnar F. Schröder,et al.  Cross-validation in cryo-EM–based structural modeling , 2013, Proceedings of the National Academy of Sciences.

[52]  S. Scheres.  RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.

[53]  Frank M LaFerla,et al.  Animal models of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[54]  Lawrence Rajendran,et al.  Role of genes linked to sporadic Alzheimer’s disease risk in the production of β-amyloid peptides , 2012, Proceedings of the National Academy of Sciences.

[55]  Zhe Wang,et al.  Real-space refinement with DireX: from global fitting to side-chain improvements. , 2012, Biopolymers.

[56]  M. Lalowski,et al.  The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ , 2012, Neurobiology of Aging.

[57]  Roland L. Dunbrack,et al.  proteins STRUCTURE O FUNCTION O BIOINFORMATICS Improved prediction of protein side-chain conformations with SCWRL4 , 2022 .

[58]  L. Lannfelt,et al.  An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease , 2009, Neurobiology of Disease.

[59]  A. Drzezga,et al.  Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease , 2009, PloS one.

[60]  K. Blennow,et al.  A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice , 2009, Neurobiology of Aging.

[61]  Richard D. Leapman,et al.  Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[62]  Dag Sehlin,et al.  Sensitive ELISA detection of amyloid‐β protofibrils in biological samples , 2007 .

[63]  J. Davis,et al.  Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid β-protein precursor transgenic mice , 2007, Neuroscience.

[64]  Brian J. Bacskai,et al.  Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease , 2006, Neurobiology of Disease.

[65]  L. Lannfelt,et al.  The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice , 2006, Neurobiology of Aging.

[66]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[67]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[68]  David J. Cummins,et al.  Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[69]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.